Markets › United States › NAS › LEXX

Lexaria Bioscience Corp

NAS:LEXXHealthcarenasdaq_composite

$2.59−0.38%LiveIn session · ≈ AED 9.51 · Market cap $5.46M · Next earnings Wed 28 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	56.0%	75.7%	71.9%	86.1%	99.0%	99.6%	—	—
Operating margin	−1,078.9%	−786.8%	−2,591.7%	−2,888.5%	−1,239.2%	−1,683.0%	−1,683.0%	+0.0 pts
Net margin	−1,023.0%	−557.2%	−2,846.3%	−2,946.4%	−1,248.2%	−1,686.0%	−1,686.0%	+0.0 pts
EBITDA margin	−1,040.9%	−555.7%	−2,850.8%	−2,903.1%	−1,234.7%	−1,674.9%	—	—
Return on equity	−155.8%	−30.4%	−91.5%	−218.9%	−72.1%	−398.1%	−457.3%	−59.2 pts
Return on assets	−139.1%	−30.4%	−92.8%	−216.1%	−65.4%	−285.1%	−285.1%	+0.0 pts
Return on capital employed	−159.4%	−43.4%	−86.6%	−232.0%	−74.1%	−443.0%	—	—
Debt / equity	0.1×	0.0×	0.0×	0.1×	0.0×	0.0×	0.0×	+14.9%
Debt / assets	5.5%	0.7%	0.6%	5.3%	1.5%	2.6%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	8.5×	81.2×	36.0×	8.2×	7.2×	2.3×	2.3×	+0.0%
Quick ratio	8.0×	81.0×	35.8×	8.2×	7.2×	2.3×	—	—
Cash ratio	5.7×	71.2×	30.0×	5.1×	5.9×	1.2×	1.2×	+0.0%
Asset turnover	0.1×	0.1×	0.0×	0.1×	0.1×	0.2×	—	—
Inventory turnover	0.9×	5.9×	1.9×	—	—	—	—	—
Receivables turnover	1.2×	2.1×	1.3×	1.3×	3.0×	4.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—